PhotoPharmics is a medical device company that develops treatments for treating neurodegenerative disorders.
PhotoPharmics has raised $6.0M in total funding. The most recent round was Series B. The last funding was announced in April 2025.
PhotoPharmics's investors include Kickstart, PC Squared, LLC.
PhotoPharmics is headquartered in Lehi, United States.
PhotoPharmics is a medical device company that develops treatments for treating neurodegenerative disorders.
PhotoPharmics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PhotoPharmics — Funding & Investors." VCBacked, April 18, 2025, https://www.vcbacked.co/company/photopharmics. Accessed October 30, 2026.
VCBacked. (2025). PhotoPharmics — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/photopharmics
{{cite web |title=PhotoPharmics — Funding & Investors |url=https://www.vcbacked.co/company/photopharmics |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated